510(k) K161691
K161691 is an FDA 510(k) premarket notification submitted by Randox Laboratories Limited for the device "Direct LDL Cholesterol (LDL)". The FDA issued a decision of Substantially Equivalent on March 20, 2017. The device falls under product code MRR (System, Test, Low Density, Lipoprotein), a Class I device regulated under 21 CFR 862.1475. Randox Laboratories Limited has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- March 20, 2017
- Date Received
- June 20, 2016
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Test, Low Density, Lipoprotein
- Device Class
- Class I
- Regulation Number
- 862.1475
- Review Panel
- CH
- Submission Type